Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Optimization in 3D Pulsed Dose Rate Brachytherapy in Locally Advanced Cervical Cancer
NCT02880007Phase 2Completed
- Sponsor
- Institut de Cancérologie de Lorraine
- Start
- Jun 2011
- Primary completion
- Feb 2014
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in Cervical Cancer (CC), sponsored by Institut de Cancérologie de Lorraine. Primary endpoint: Local Control Rate at 24 months. Started Jun 2011; status: completed.
02
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02880007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02880007.